secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vyome Holdings, Inc (HIND)
CIK:        0001427570
Form:       8-K
Filed at:   2025-04-28T23:59:59+00:00
Accession:  0001104659-25-040184
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ReShape Lifesciences amends asset purchase deal; price cut to $2.25M, deadline to June 30
--------------------------------------------------------------------------------

- Exercise price under Asset Purchase Agreement reduced from $5.16M to $2.25M.
- Termination date extended from March 31, 2025 to June 30, 2025.
- Amendment dated April 25, 2025, between ReShape and Ninjour Health International Limited.
- Original Asset Purchase Agreement was entered into on July 8, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1427570/000110465925040184/0001104659-25-040184-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1427570/000110465925040184/tm2513212d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-040184

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer